BNT162b2 mRNA Vaccination Leads to Long-Term Protection from COVID-19 Disease

The efficacy of SARS-CoV-2 mRNA-based vaccines in preventing COVID-19 disease has been extensively demonstrated; however, it is of uttermost importance to acquire knowledge on the persistence of immune-protection both in terms of levels of neutralizing antibodies and specialized memory cells. This c...

Full description

Bibliographic Details
Published in:Vaccines
Main Authors: Claudia Rossi, Paola Lanuti, Ilaria Cicalini, Domenico De Bellis, Laura Pierdomenico, Piero Del Boccio, Mirco Zucchelli, Luca Natale, Bruna Sinjari, Giulia Catitti, Simone Vespa, Pasquale Simeone, Giuseppina Bologna, Ines Bucci, Katia Falasca, Jacopo Vecchiet, Liborio Stuppia, Vincenzo De Laurenzi, Damiana Pieragostino
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Subjects:
BNT162b2
SARS-CoV-2
vaccines
anti-S1 IgG
spike-specific T-cells
Online Access:https://www.mdpi.com/2076-393X/9/10/1164

Internet

https://www.mdpi.com/2076-393X/9/10/1164

Similar Items